Product name: |
Oncept IL-2 |
Active substance: |
Canarypox virus expressing Feline interleukin-2, Live (vCP1338) |
Target tribe: |
kočky |
Drug form: |
Lyofilizát a rozpouštědlo pro injekční suspenzi |
Registration date: |
3. 5. 2013 |
Registration number: |
EU/2/13/150 |
Verdict holder: |
Boehringer Ingelheim Vetmedica, GmbH Binger Strasse 173 Ingelheim am Rhein 55216 Phone: , Fax: Email: |
ATC vet. code: |
QL03A - Other immunostimulants |
Pharmacotherapeutic group: |
IMMUNOSTIMULANTS |
Narcotics: |
NO |
Indication restriction: |
NO |
Withdrawal period: |
|
Procedure type: |
Centralised |
Table of active package codesPackage code | Size | Package type | Material | Identification code | EU number | Issue |
---|
9908036 | 6 x 1 dávka | injekční lahvička | sklo | - | - | Na předpis |
Package code | Size | Package type | Material | Identification code | EU number | Issue |
---|
9902636 | 1 x 6 dávka | injekční lahvička | sklo | zrušeno-převod | - | Na předpis |
|